These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36631971)

  • 21. Water-soluble gambogic acid PEGylated prodrugs: synthesis, characterization, physicochemical properties and in vitro hydrolysis.
    Tang X; Zhang P; Ye H; Zhang C; Shen W; Ping Q
    Pharmazie; 2008 Oct; 63(10):711-7. PubMed ID: 18972831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
    Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
    Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: Effect of PEG length on antitumor efficacy.
    Mu J; Zhong H; Zou H; Liu T; Yu N; Zhang X; Xu Z; Chen Z; Guo S
    J Control Release; 2020 Oct; 326():265-275. PubMed ID: 32687940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
    Li M; Liang Z; Sun X; Gong T; Zhang Z
    PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin.
    Marcus Y; Sasson K; Fridkin M; Shechter Y
    J Med Chem; 2008 Jul; 51(14):4300-5. PubMed ID: 18578475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disulfide-based PEGylated prodrugs: Reconversion kinetics, self-assembly and antitumor efficacy.
    Xie Z; Song J; Zhang H; Zhuang Y; Xie S; Li Y; Li Z; Liu M; Sun K
    Colloids Surf B Biointerfaces; 2018 Dec; 172():414-422. PubMed ID: 30195159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells.
    Thapa P; Li M; Karki R; Bio M; Rajaputra P; Nkepang G; Woo S; You Y
    ACS Omega; 2017 Oct; 2(10):6349-6360. PubMed ID: 29104951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways.
    Abdallah M; Lin L; Styles IK; Mörsdorf A; Grace JL; Gracia G; Nowell C; Quinn JF; Landersdorfer CB; Whittaker MR; Trevaskis NL
    Acta Biomater; 2024 Jan; 174():191-205. PubMed ID: 38086497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo anti-tumor activity of polypeptide HM-3 modified by different polyethylene glycols (PEG).
    Liu Z; Ren Y; Pan L; Xu HM
    Int J Mol Sci; 2011; 12(4):2650-63. PubMed ID: 21731464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates.
    Santi DV; Schneider EL; Reid R; Robinson L; Ashley GW
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6211-6. PubMed ID: 22474378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.
    Ling X; Tu J; Wang J; Shajii A; Kong N; Feng C; Zhang Y; Yu M; Xie T; Bharwani Z; Aljaeid BM; Shi B; Tao W; Farokhzad OC
    ACS Nano; 2019 Jan; 13(1):357-370. PubMed ID: 30485068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereocomplex Prodrugs of Oligo(lactic acid)
    Tam YT; Huang C; Poellmann M; Kwon GS
    ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomes as carriers for colchicine-derived prodrugs: vascular disrupting nanomedicines with tailorable drug release kinetics.
    Crielaard BJ; van der Wal S; Le HT; Bode AT; Lammers T; Hennink WE; Schiffelers RM; Fens MH; Storm G
    Eur J Pharm Sci; 2012 Mar; 45(4):429-35. PubMed ID: 21907797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
    Li Y; Lu H; Liang S; Xu S
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.
    Zhou L; Cheng R; Tao H; Ma S; Guo W; Meng F; Liu H; Liu Z; Zhong Z
    Biomacromolecules; 2011 May; 12(5):1460-7. PubMed ID: 21332185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature.
    Chen Y; Zhang M; Jin H; Tang Y; Wang H; Xu Q; Li Y; Li F; Huang Y
    Biomaterials; 2017 Feb; 116():57-68. PubMed ID: 27914267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEGylation of the peptide Bac7(1-35) reduces renal clearance while retaining antibacterial activity and bacterial cell penetration capacity.
    Benincasa M; Zahariev S; Pelillo C; Milan A; Gennaro R; Scocchi M
    Eur J Med Chem; 2015 May; 95():210-9. PubMed ID: 25817771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteins.
    Zhao H; Yang K; Martinez A; Basu A; Chintala R; Liu HC; Janjua A; Wang M; Filpula D
    Bioconjug Chem; 2006; 17(2):341-51. PubMed ID: 16536464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.